Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 2—February 2009

Research

Seoul Virus and Hantavirus Disease, Shenyang, People’s Republic of China

Yong-Zhen ZhangComments to Author , Xue Dong, Xin Li, Chao Ma, Hai-Ping Xiong, Guang-Jie Yan, Na Gao, Dong-Mei Jiang, Ming-Hui Li, Lu-Ping Li, Yang Zou, and Alexander Plyusnin
Author affiliations: Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China (Y.-Z. Zhang, C. Ma, H.-P. Xiong, N. Gao, Y. Zou); Shenyang Center for Disease Control and Prevention, Shenyang, People’s Republic of China (X. Dong, X. Li, M.-H. Li); Shenhe District Center for Disease Control and Prevention, Shenyang (G.-J. Yan, D.-M. Jiang); Shenyang Infectious Disease Hospital, Shenyang (L.-P. Li); Haartman Institute, University of Helsinki, Helsinki, Finland (A. Plyusnin)

Main Article

Table 2

Serologic analysis of samples from HFRS patients by indirect IFA, Shenyang, China, 2006*

Serum sample no. IgM assay†
IgG assay†
SEOV HTNV SEOV HTNV
1/06 40 20 640 160
2/06 40 20 320 80
3/06 40 320 80
4/06 20 320 160
5/06 40 320 80
6/06 40 20 160 20
7/06 40 20 320 80
8/06 40 320 160

*HFRS, hemorraghic fever with renal syndrome; IFA, immunofluorescent assay; Ig, immunoglobulin; SEOV, Seoul virus; HTNV, hantaan virus; –, could not be detected.
†Numbers represent the endpoint titers of anti-hantavirus (SEOV or HTNV) antibodies in the patients’ serum samples.

Main Article

TOP